A cross-sectional study to determine the outcomes of psoriasis patients and their relationship with depression
outcomes of psoriasis patients and their relationship with depression.
Keywords:
DLQI, Depressive, Psoriasis, Facial lesionsAbstract
Objective To determine the type of relationship generated between psoriasis and the severity of depression and anxiety.  Methods Sixty patients with psoriasis from different hospitals in Thi-Qar, Iraq, with ages ranging from 30 to 60 years were enrolled in the study. The patients were distributed according to gender, with 40 women and 20 males. A DLQI Life Quality Index Score questionnaire was used to assess depression and anxiety levels in the patients. We depend on Scale (HADS)as an indicator for measuring anxiety and depression in psoriasis patients, which consists of 14 items, seven related to anxiety and seven related to depression. The study followed the binding rules of clinical practice and obtained consent from the participants. The study period lasted for a year from March 2020 to April 2021.  Results The study found that 40% of the psoriasis patients had a level of depression higher than the average, indicating a significant correlation between depressive activity and the severity and prevalence of psoriasis; the patients' work was measured using the mean±SD which was found suggesting potential impacts on their quality of life. The distribution of psoriasis lesions among the patients showed that most patients suffered from upper limb lesions (66.6%), scalp lesions (58.3%) and facial lesions (50%).  Conclusion We concluded there is impact with a statistically significant relationship of psoriasis on the patients' quality of life, as measured by the DLQI score, indicating potential impacts on work and overall well-being. ÂReferences
Griffiths CE, Armstrong AW, Gudjonsson JE, Barker JN. Psoriasis. The Lancet. 2021;397(10281):1301-15.
Ding X, Wang T, Shen Y, Wang X, Zhou C, Tian S, et al. Prevalence of psoriasis in China: a population-based study in six cities. Eur J Dermatol. 2012;22(5):663-7.
Parisi R, Iskandar IY, Kontopantelis E, Augustin M, Griffiths CE, Ashcroft DMNational, regional, and worldwide epidemiology of psoriasis: a systematic analysis and modelling study. BMJ. 2020;369:m1590.
Ryan C, Sadlier M, De Vol E, Patel M, Lloyd AA, Day A, et al. Genital psoriasis is associated with significant impairment in quality of life and sexual functioning. J Am Acad Dermatol. 2015;72(6):978-83.
Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol. 1985;13(3):450-6.
Alonso S, Tejón P, Sarasqueta C, Coto P, Alperi M, Queiro R. Age at disease onset may help to further characterize the disease phenotype in psoriatic arthritis. Joint Bone Spine. 2016;83(5):533-7.
Patel N, Nadkarni A, Cardwell LA, Vera N, Frey C, Patel N, et al. Psoriasis, depression, and inflammatory overlap: a review. Am J Clin Dermatol. 2017;18:613-20.
Dalgard FJ, Svensson A, Gieler U, Tomas-Aragones L, Lien L, Poot F, et al. Dermatologists across Europe underestimate depression and anxiety: results from 3635 dermatological consultations. Br J Dermatol. 2018;179:464-70.
Langley RG, Ellis CN. Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment. J Am Acad Dermatol. 2004;51(4):563-9.
Kuang Y, Xiao Y, Fang Z, Zhang Y, Shen M, Chen X, Chen M, Lv C, Zhu W. Association of Serum Vitamin D With Psoriasis and Effect Modification by Central Obesity. Front Med (Lausanne). 2020;18;7:236.
Lamb RC, Matcham F, Turner MA, Rayner L, Simpson A, Hotopf M, et al. Screening for anxiety and depression in people with psoriasis: a cross-sectional study in a tertiary referral setting. Br J Dermatol. 2017;176(4):1028-34.
Vrublevska J, Trapencieris M, Rancans E. Adaptation and validation of the Patient Health Questionnaire-9 to evaluate major depression in a primary care sample in Latvia. Nordic J Psychiat, 2018;72(2):112-8.
Jin W, Zhang S, Duan Y. Depression symptoms predict worse clinical response to etanercept treatment in psoriasis patients Dermatology. 2019;235:55-64.
Bosanquet K, Bailey D, Gilbody S, Harden M, Manea L, Nutbrown S, et al. Diagnostic accuracy of the Whooley questions for the identification of depression: a diagnostic meta-analysis. BMJ Open. 2015;5: e008913.
Ahmadi F, Hussin NAM, Mohammad MT. Religion, Culture and Meaning-Making Coping: a study among cancer patients in Malaysia. J Relig Health. 2019;58:1909e1924.
Fortune DG, Main CJ, O’Sullivan TM, Griffiths CEM. Assessing illness-related stress in psoriasis: the psychometric properties of the Psoriasis Life Stress Inventory. J Psychosom Res. 1997;42(5):467e475.
Kuang Y, Xiao Y, Fang Z, Zhang Y, Shen M, Chen X, et al. . Association of serum vitamin D with psoriasis and effect modification by central obesity. Front Med (Lausanne). 2020;8:771645.
Joseph J, Golden S. Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus. Ann N Y Acad Sci. 2017;1391:20-34.
Milaneschi Y, Simmons W, van Rossum E, Penninx B. Depression, and obesity: evidence of shared biological mechanisms. Mol Psychiatry. 2019;24:18-33.
